Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ristow

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Transplantation|January 25, 2005
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?Irene M Ghobrial, Thomas M Habermann, William R Macon, et al.
Blood Advances|March 4, 2021
Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab eraArushi Khurana, Mattia Novo, Grzegorz S Nowakowski, et al.
Diabetes|May 20, 1998
An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) geneM Ristow, E Giannakidou, J Hebinck, et al.
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Leukemia & Lymphoma|September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.
Blood Cancer Journal|January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphomaAlessia Castellino, Aung M Tun, Yucai Wang, et al.
Blood|July 15, 2004
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeAnne J Novak, Deanna M Grote, Mary Stenson, et al.
Leukemia & Lymphoma|February 20, 2014
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphomaLuis F Porrata, Kay M Ristow, Thomas M Habermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphomaJacob P Smeltzer, Jason M Jones, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disordersIrene M Ghobrial, Thomas M Habermann, Matthew J Maurer, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Transplantation|January 25, 2005
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?Irene M Ghobrial, Thomas M Habermann, William R Macon, et al.
Blood Advances|March 4, 2021
Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab eraArushi Khurana, Mattia Novo, Grzegorz S Nowakowski, et al.
Diabetes|May 20, 1998
An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) geneM Ristow, E Giannakidou, J Hebinck, et al.
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Leukemia & Lymphoma|September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.
Blood Cancer Journal|January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphomaAlessia Castellino, Aung M Tun, Yucai Wang, et al.
Blood|July 15, 2004
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeAnne J Novak, Deanna M Grote, Mary Stenson, et al.
Leukemia & Lymphoma|February 20, 2014
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphomaLuis F Porrata, Kay M Ristow, Thomas M Habermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphomaJacob P Smeltzer, Jason M Jones, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disordersIrene M Ghobrial, Thomas M Habermann, Matthew J Maurer, et al.
Pageof 7